A judge has signed off on a class action settlement that will see Retail Food Group pay nothing to the current and former franchisees of its Michel’s Patisserie chain.
Johnson Winter Slattery has bolstered the ranks of its industrial relations and employment team, luring a new partner and special counsel away from Corrs Chambers Westgarth.
Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.
The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.
AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta.
Years of hard fought litigation by axed Qantas ground crew and generic drug maker Sandoz ended in victory this week, thanks to legal eagles from Maurice Blackburn and Ashurst and their counsel. The week opened with a bang with a decision from Federal Court Justice Michael Lee in three landmark test cases by the Transport…
The scope of protection for geographical indications will be at issue in India’s appeal of a decision that barred it from registering a trade mark for basmati rice.
INPEX has won a bid to cross-examine AkzoNobel’s solicitors about discovery at the end of an 11-week trial over allegedly defective paint used on the $45 billion Ichthys natural gas project.
Novartis unit Sandoz is appealing a tribunal decision in favour of pharmaceutical company Lundbeck over a licence to sell a generic version of leading antidepressant Lexapro.
A Victorian barrister found guilty of contempt for representing her sons despite an order barring her from practicing can’t re-open reviews of two decisions denying her a certificate.